Physician profile
Faisal Shaikh
NPI 1154530988
$5,457.13
in general payments reported to CMS, 2019-2025
30 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,940 · 2020: $108 · 2021: $316 · 2022: $1,477 · 2023: $197 · 2024: $176 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $2,451.26 | 2019 | |
| Intuitive Surgical, INC. | $1,276.96 | 2022 | |
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Abbott Laboratories | $188.22 | 2019-2024 | Coroflow |
| E.R. Squibb & Sons, L.L.C. | $109.32 | 2019-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.06 | 2019-2024 | Jardiance |
| Boston Scientific Corporation | $96.97 | 2019-2023 | Watchman Access System |
| Opsens INC. | $96.47 | 2019-2020 | |
| Medtronic, INC. | $85.18 | 2021-2025 | Azure Xt Dr Mri Surescan |
| Kestra Medical Technology Services, INC. | $82.79 | 2023 | Assure Wcd |
| Edwards Lifesciences Corporation | $78.08 | 2019-2020 | |
| Pfizer INC. | $60.03 | 2019-2023 | |
| Shockwave Medical, INC | $59.76 | 2025 | |
| Cardiovascular Systems INC. | $56.14 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $53.93 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $49.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $48.43 | 2019-2024 | |
| Portola Pharmaceuticals, LLC | $42.08 | 2019 | |
| Alnylam Pharmaceuticals INC. | $38.93 | 2025 | Onpattro |
| Merck Sharp & Dohme LLC | $35.79 | 2021-2022 | |
| Avanos Medical | $33.46 | 2025 | Enfit |
| Cvrx, INC. | $33.17 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.20 | 2019 | |
| Novo Nordisk INC | $25.55 | 2025 | Wegovy |
| Heartflow, INC. | $24.84 | 2025 | |
| Atricure, INC. | $24.77 | 2023 | |
| Medtronic Vascular, INC. | $24.76 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.76 | 2019 | |
| Ekos Corporation | $15.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Shaikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.